One and Two-Step In Vitro-In Vivo Correlations Based on USP IV Dynamic Dissolution Applied to Four Sodium Montelukast Products
Montelukast is a weak acid drug characterized by its low solubility in the range of pH 1.2 to 4.5, which may lead to dissolution-limited absorption. The aim of this paper is to develop an in vivo predictive dissolution method for montelukast and to check its performance by establishing a level-A in...
Saved in:
Main Authors: | Mercedes Prieto-Escolar (Author), Juan J. Torrado (Author), Covadonga Álvarez (Author), Alejandro Ruiz-Picazo (Author), Marta Simón-Vázquez (Author), Carlos Govantes (Author), Jesús Frias (Author), Alfredo García-Arieta (Author), Isabel Gonzalez-Alvarez (Author), Marival Bermejo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products
by: Isabel Gonzalez-Alvarez, et al.
Published: (2021) -
Candesartan Cilexetil In Vitro-In Vivo Correlation: Predictive Dissolution as a Development Tool
by: Andrés Figueroa-Campos, et al.
Published: (2020) -
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug
by: Isabel Gonzalez-Alvarez, et al.
Published: (2024) -
In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
by: Marival Bermejo, et al.
Published: (2020) -
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients
by: Isabel González-Álvarez, et al.
Published: (2022)